Carl Deffenbaugh – US Market Buzz

National Bank of Greece (ADR)(NYSE:NBG): How Paid Members Made 27% In Just 4 Sessions

Carl Deffenbaugh — Fri, 20 Feb 2015 18:02:43 +0000

Well, as we know there are two types of person in the stock market one is trader and another is investor. Investors tend to put money for longer time, while traders make short term bets. We know, its not at all easy to make money in the short term especially in the equity markets. However, premium members at Special Penny Stocks Alert are making awesome money on our calls. Here are some of our calls this year.

We at Special Penny Stocks Alert.com scan various stocks and alert to our premium (paid) members based on the technical factors. Over the past two months, they have made huge money on our calls like ADXS, FRO, AGIO, TTPH, AGEN, IDRA, ACHN. If you want to make money without doing any homework, just join our membership. You can send us your request at specialpennystockalert.com@gmail.com

Now let me show you how we made quick 27% in just 4 sessions which were bring posted to our premium members:-

We told our members in facebook private group to buy National Bank of Greece (ADR)(NYSE:NBG) on February 17th at $1.56. Now look at the price of the stock, it’s 27% from our buy call and now at $1,97. This is how easy money they made. It’s not yet late, join us at specialpennystockalert.com@gmail.com

Exelixis, Inc. (NASDAQ:EXEL): Premium Members Made An Easy 10% In No Time

Carl Deffenbaugh — Tue, 10 Feb 2015 20:47:32 +0000

Now let me show you how we made quick 10% in just 3 sessions which were bring posted to our premium members:-

We told our members in facebook private group to buy Exelixis, Inc. (NASDAQ:EXEL) on February 6th at $1.99. Now look at the price of the stock, it’s 10% from our buy call and now at $2.20. This is how easy money they made. It’s not yet late, join us at specialpennystockalert.com@gmail.com

Novavax, Inc. (NASDAQ:NVAX): Premium Members Made An Easy 20% In No Time

Carl Deffenbaugh — Wed, 21 Jan 2015 17:31:07 +0000

Now let me show you how we made quick 20% in just 2 session which were bring posted to our premium members:-

We told our members in facebook private group to buy Novavax, Inc. (NASDAQ:NVAX) on January 16th at $6.50. Now look at the price of the stock, it’s 20% from our buy call in given time and now at $7.74. This is how easy money they made. It’s not yet late, join us at specialpennystockalert.com@gmail.com

Kite Pharma Inc (NASDAQ:KITE): Our Premium Members Made 10% In One Session

Carl Deffenbaugh — Mon, 05 Jan 2015 17:10:33 +0000

We at Special Penny Stocks Alert.com scan various stocks and alert to our premium (paid) members based on the technical factors. Over the past two months, they have made huge money on our calls like AGIO, TTPH, KNDI, IBIO, LAKE, RADA. If you want to make money without doing any homework, just join our membership. You can send us your request at specialpennystockalert.com@gmail.com.

Now let me show you how we made quick 10% in just 1 session which were bring posted to our premium members:-

Firstly we told our members in facebook private group to buy Kite Pharma Inc (NASDAQ:KITE) on 02nd January at $59.80. Now look at the price of the stock, it’s 10% from our buy call and now at $66. This is how easy money they made. It’s not yet late, join us at specialpennystockalert.com@gmail.com

Special News Alert: AngloGold Ashanti Limited (ADR) (NYSE:AU), Foot Locker, Inc. (NYSE:FL), Eldorado Gold Corp. (NYSE:EGO)

Carl Deffenbaugh — Mon, 22 Dec 2014 15:03:13 +0000

Lakeway, NY — (MARKET NEWS CALL) — 12/22/2014— thenextbigtrade.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market about the small and penny stocks, issues news alert on AngloGold Ashanti Limited (ADR) (NYSE:AU), Foot Locker, Inc. (NYSE:FL), Eldorado Gold Corp. (NYSE:EGO).

AngloGold Ashanti Limited (ADR) (NYSE:AU) shares increased 0.58% to $8.73. The company on Nov. 3 narrowed its production outlook for the year to the top end of the initial guidance range and reduced its capital expenditure forecast. Production was 1.128Moz at a total cash cost of $820/oz for the three months to September 30, compared to 1.043Moz at a total cash cost of $809/oz in the corresponding period of last year. Guidance for the quarter was for 1.06Moz – 1.09Moz at $850/oz – $890/oz.

Should Investors Buy AU After The Recent Development? Find Out Here

Foot Locker, Inc. (NYSE:FL)’s shares decreased 6.95% to $53.86. The company on Dec. 9 launched its “Ready to Fly” campaign featuring NBA star Russell Westbrook. The 60-second commercial opens with Westbrook approaching an aspiring basketball star and taking him through all of the “typical” steps today’s top athletes have to complete before making it big. Adding a bit of levity and humor, Spike Lee jeers at the young player as he works through Westbrook’s grueling drills.

Is FL Going To Rise or Fall After Today’s Price Action? Find Out Here

Additionally, the company on Nov. 21 reported financial results for its third quarter ended November 1, 2014. Net income for the Company’s third quarter ended November 1, 2014 was $120 million, or $0.82 per share, compared with net income of $104 million, or $0.70 per share, last year, an increase in earnings per share of 17 percent. Net income for the Company’s first nine months of the year increased to $374 million, or $2.55 per share, compared to net income of $308 million, or $2.04 per share, for the corresponding period in 2013. Earnings per share for the nine-month period increased 25 percent compared to the same period in 2013.

Eldorado Gold Corp. (NYSE:EGO)’s shares gained 0.63% to $6.42. The company on Oct. 30 reported the Company’s financial and operational results for the third quarter ended September 30, 2014. During the quarter, the Company generated $263.5 million in revenues from metal sales, and adjusted net earnings of $36.1 million ($0.05 per share). Cash flow from operating activities for the quarter totalled $92.2 million ($0.13 per share). Net income attributable to shareholders of the Company for the quarter was $19.8 million (or $0.03 per share), compared with $36.4 million (or $0.05 per share) in the third quarter of 2013.

Can Traders Buy EGO After The Solid Rally? Get Free Trend Analysis Here

About thenextbigtrade.com

thenextbigtrade.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. thenextbigtrade.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed “informational edge” which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at Specialpennystockalert.com.

Disclaimer

The assembled information disseminated by thenextbigtrade.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. thenextbigtrade.com does expect that investors will buy and sell securities based on information assembled and presented in thenextbigtrade.com. PLEASE always do your own due diligence, and consult your financial advisor.

Special News Alert: Sprint Corporation (NYSE:S), AT&T, Inc. (NYSE:T), Ally Financial Inc (NYSE:ALLY)

Carl Deffenbaugh — Mon, 22 Dec 2014 13:50:30 +0000

Lakeway, NY — (MARKET NEWS CALL) — 12/22/2014— thenextbigtrade.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market about the small and penny stocks, issues news alert on AT&T, Inc. (NYSE:T), Sprint Corporation(NYSE:S), Ally Financial Inc (NYSE:ALLY).

AT&T, Inc. (NYSE:T)’s shares climbed 0.09% to $33.54. The company on Dec. 19 announced that its board of directors has approved a 2.2 percent increase in the company’s quarterly dividend. AT&T directors increased the quarterly dividend rate from $0.46 to $0.47 a share on a quarterly basis, or an increase from $1.84 to $1.88 per share on an annualized basis.

Should Investors Buy T After The Recent Development? Find Out Here

Additionally, the company on Dec. 16 announced the appointment of Jeni Bell as vice president and general manager of the AT&T Mobility sales organization for the Rocky Mountain Region, which is comprised of Colorado, Utah, Idaho, Montana, and Wyoming. In her new role, Bell is responsible for the successful operation and overall performance of this five-state territory, including business development, revenue growth, product launches, and customer acquisition, satisfaction, and retention.

Sprint Corporation(NYSE:S)’s shares jumped 1.96% to $4.16. Moody’s Investors Service on Dec. 17 downgraded several ratings of Sprint Corporation including the company’s Corporate Family Rating (“CFR”) to B1 from Ba3, the company’s Probability of Default Rating (“PDR”) to B1-PD from Ba3-PD, Sprint’s senior unsecured rating to B2 from B1 and lowered the company’s Speculative Grade Liquidity Rating to SGL-3 from SGL-1.

Is S Going To Rise or Fall After Today’s Price Action? Find Out Here

Additionally, Sprint (NYSE:S), Techstars and the University of Kansas Medical Center on Dec. 17 announced they will be working together to support mobile health startups. KU Medical Center will lend mentorship and expertise to early-stage companies whose products focus on increasing the accessibility to quality health care services at next spring’s Sprint Mobile Health Accelerator, Powered by Techstars.

Ally Financial Inc (NYSE:ALLY)’s stock climbed 2.24% to $23.26. The company on Dec. 19 announced that the U.S. Department of the Treasury has sold its remaining 54.9 million shares of Ally common stock at $23.25 per share and as a result, Ally will have exited the Troubled Asset Relief Program (TARP) upon settlement of the sale. The U.S. Treasury received $19.6 billion in total on the $17.2 billion Ally investment, which is $2.4 billion more than originally invested. Ally entered TARP in December 2008 as part of the effort to stabilize and strengthen the U.S. auto industry, and today is a leading auto finance provider.

Can Traders Buy ALLY After The Solid Rally? Get Free Trend Analysis Here

About thenextbigtrade.com

Disclaimer

Stocks Alert: Weatherford International Ltd(NYSE:WFT), Kinross Gold Corporation (USA)(NYSE:KGC), Genworth Financial Inc (NYSE:GNW)

Carl Deffenbaugh — Fri, 19 Dec 2014 15:16:33 +0000

Lakeway, NY — (US MARKET BUZZ) — 12/19/2014— thenextbigtrade.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market about the small and penny stocks, issues news alert on Weatherford International Ltd(NYSE:WFT), Kinross Gold Corporation (USA)(NYSE:KGC), Genworth Financial Inc (NYSE:GNW).

Weatherford International Ltd(NYSE:WFT)’s shares jumped 2.81% to $11.70. The company announced that it has scheduled a conference call for Feb. 5, 2015 at 8:30 a.m. ET. The purpose of the conference call is to discuss results for the Company’s fourth quarter ended Dec. 31, 2014.

Should Investors Buy WFT After The Recent Development? Find Out Here

Additionally, in a report published on Dec. 3, Oppenheimer analyst James Schumm initiated coverage on shares of WFT with an Outperform rating and $19.00 price target.

Kinross Gold Corporation (USA)(NYSE:KGC)’s shares jumped 8.24% to $2.89. The company on Dec. 17 completed the sale of all of its interest in Aurelian Resources Inc. (“ARI”) and the Fruta del Norte project in Ecuador to Fortress Minerals Corp. (“Fortress”), a member of the Lundin Group of Companies, for US$240 million, consisting of US$150 million in cash and US$90 million in Fortress common shares.

Is KGC Going To Rise or Fall After Today’s Price Action? Find Out Here

Further to the Company’s news release dated October 21, 2014 announcing the sale, Kinross received 26,156,250 Fortress common shares, issued at a price of C$4.00 per share, resulting in Kinross owning approximately 25.8% of Fortress’ outstanding common shares.

Genworth Financial Inc (NYSE:GNW)’s shares gained 0.76% to $7.99. The company on Dec. 17 announced that it is still in the process of completing its annual review of long term care insurance active life margins. The scope of this review includes GAAP loss recognition and statutory cash flow testing. Given progress to date, the company anticipates communicating results of the active life margin review after completion of a peer review by an independent third party in 2015, on or before the company’s fourth quarter earnings conference call.

Can Traders Buy GNW After The Solid Rally? Get Free Trend Analysis Here

About thenextbigtrade.com

Disclaimer

Traders Buzz: IGI Laboratories, Inc.(NYSEMKT:IG), Immune Design Corp(NASDAQ:IMDZ), Akebia Therapeutics Inc(NASDAQ:AKBA)

Carl Deffenbaugh — Thu, 18 Dec 2014 13:45:50 +0000

Lakeway, NY — (MARKET NEWS CALL) — 12/18/2014— thenextbigtrade.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market about the small and penny stocks, issues news alert on IGI Laboratories, Inc.(NYSEMKT:IG), Immune Design Corp(NASDAQ:IMDZ), Akebia Therapeutics Inc(NASDAQ:AKBA).

IGI Laboratories, Inc.(NYSEMKT:IG)’s stock gained 7.63% to $9.45. The company on Dec. 17 announced the closing of its offering of $125 million aggregate principal amount of 3.75% Convertible Senior Notes due 2019 (the “Notes”). The Notes were offered and sold only to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

Should Investors Buy IG After The Recent Development? Find Out Here

The Notes bear interest at a fixed rate of 3.75% per year, payable semiannually in arrears on June 15 and December 15 of each year, beginning on June 15, 2015 and mature on December 15, 2019, unless earlier repurchased, redeemed or converted. The Notes are convertible into shares of IGI’s common stock, cash or a combination thereof.

Immune Design Corp(NASDAQ:IMDZ)’s stock gained 7.63% to $23.84. The company on Nov. 12 reported financial results for the third quarter ended September 30, 2014. IMDZ ended the third quarter of 2014 with $83.4 million in cash and cash equivalents compared to $18.0 million at the end of the second quarter. General and administrative expenses for the third quarter of 2014 were $4.1 million, compared to $1.1 million for the third quarter of 2013. Net loss for the third quarter of 2014 was $6.7 million, compared to $4.0 million for the third quarter 2013.

Is IMDZ Going To Rise or Fall After Today’s Price Action? Find Out Here

Akebia Therapeutics Inc(NASDAQ:AKBA)’s shares climbed 7.62% to $11.87. The company on Dec. 15 announced that it has been selected for addition to the NASDAQ Biotechnology Index (^NBI). The annual re-ranking of the NASDAQ Biotechnology Index will become effective upon market open on Monday, December 22, 2014.

Can Traders Buy AKBA After The Solid Rally? Get Free Trend Analysis Here

Additionally, the company on Nov. 17 announced that John P. Butler, President and Chief Executive Officer of Akebia, has established a personal stock purchasing plan to acquire shares of the company’s common stock. The purchasing plan complies with Section 10b5-1 of the Securities Exchange Act of 1934, as amended, which enables securities holders to adopt pre-arranged stock purchasing plans for the acquisition of predetermined amounts of securities on a non-discretionary basis.

About thenextbigtrade.com

Disclaimer

Watch List: Neuralstem, Inc. (NYSEMKT:CUR), Oragenics Inc(NYSEMKT:OGEN), Codexis, Inc. (NASDAQ:CDXS)

Carl Deffenbaugh — Thu, 18 Dec 2014 13:24:53 +0000

Lakeway, NY — (MARKET NEWS CALL) — 12/18/2014— thenextbigtrade.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market about the small and penny stocks, issues news alert on Neuralstem, Inc. (NYSEMKT:CUR), Oragenics Inc(NYSEMKT:OGEN), Codexis, Inc. (NASDAQ:CDXS).

Neuralstem, Inc. (NYSEMKT:CUR)’s shares jumped 13.92% to $2.70. The company on Nov. 17 announced that blood-based biomarkers for major depressive disorder (MDD) identified a rapid response to NSI-189 in the Phase Ib MDD trial. In the poster “Biomarker Profiling of NSI-189 Phosphate, a Neurogenic Compound, in Patients with Major Depressive Disorder (MDD) during a Phase Ib Randomized Double-Blind, Placebo-Controlled Trial,” presented on Friday at the CNS Summit in Boca Raton, FL (http://www.cnssummit.org), researchers concluded that NSI-189 is rapidly and persistently efficacious. Furthermore, they suggest that it may be possible to predict a patient’s response to the drug from baseline biomarker profiling.

Should Investors Buy CUR After The Recent Development? Find Out Here

Oragenics Inc(NYSEMKT:OGEN)’s shares increased 13.75% and closed at $0.97 in yesterday’s session. On December 5, 2014, the Compensation Committee of the Board of Directors (the “Compensation Committee”) of Oragenics, Inc. authorized increases in the annual salary for the Company’s named executive officers currently employed with the Company. The foregoing changes are effective commencing January 1, 2015.

Is OGEN Going To Rise or Fall After Today’s Price Action? Find Out Here

On December 5, 2014 the Board of Directors also met and approved a change in Dr. Handfield’s title from Vice President, Research and Development to Senior Vice President of Discovery Research.

Codexis, Inc. (NASDAQ:CDXS)’s shares gained 13.60% to $2.59. The company on Dec. 3 announced that it has developed a novel enzyme therapeutic product candidate for the potential treatment of phenylketonuria (PKU) via oral administration. PKU is an inherited metabolic disorder in which the enzyme that converts the essential amino acid phenylalanine into tyrosine is deficient. As a result, phenylalanine accumulates in high levels in the brain causing serious neurological problems, including intellectual disability, seizures and cognitive and behavioral problems. Phenylalanine is found in many foods, including meat, dairy products, fish, poultry and many fruits and vegetables.

Can Traders Buy CDXS After The Solid Rally? Get Free Trend Analysis Here

About thenextbigtrade.com

Disclaimer

Stocks in Action: Molycorp, Inc. (NYSE:MCP), Fifth Street Finance Corp. (NASDAQ:FSC), ARMOUR Residential REIT, Inc.(NYSE:ARR)

Carl Deffenbaugh — Mon, 14 Jul 2014 17:57:59 +0000

Fifth Street Finance Corp. (NASDAQ:FSC)’s shares gained 1.29% to $9.86. The company on July 11 announced that it priced a public offering of 13,250,000 shares of its common stock at a public offering price of $9.95 per share for total gross proceeds of $131,837,500. All shares are being offered by FSC. Morgan Stanley, UBS Investment Bank, Deutsche Bank Securities and RBC Capital Markets will act as lead book-running managers, and SMBC Nikko will act as joint lead manager for the offering. The closing of the transaction is subject to customary closing conditions and the shares are expected to be delivered on or about July 15, 2014. FSC has also granted the underwriters an option to purchase up to an additional 1,987,500 shares of common stock.

Get the Inside Scoop On FSC here with this Free Report

ARMOUR Residential REIT, Inc.(NYSE:ARR)’s shares climbed 0.94% to $4.29. The company on July 3 confirmed the Q3 2014 monthly cash dividends for the Company’s Common Stock and Series A and Series B Preferred Stock. ARMOUR has elected to be taxed as a real estate investment trust (“REIT”) for U.S. Federal income tax purposes. In order to maintain this tax status, ARMOUR is required to timely distribute substantially all of its ordinary REIT taxable income.

You won’t believe what we found out about ARR

Molycorp, Inc. (NYSE:MCP)’s shares gained 1.88% to $2.17. Molycorp mentioned positively at DA Davidson on July 10. After speaking with management of MCP, DA Davidson says it remains optimistic that the company’s production rates are improving. It has a Buy rating on the stock with a $7 price target.

Why Should You Buy MCP Now? Get The Free Trend Analysis Here

The 52 week trading range for the company is $1.61 – $8.06. The shares of the company plunged 65% in the last one year. The company provides Rare Earths and Molybdenum products to companies. The Company’s rare earth products comprise of bastnasite, cerium, europium, lanthanum, neodymium, praseodymium, yttrium, and other lanthanides.